Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug) (SOR/2020-213)
Full Document:
- HTMLFull Document: Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug) (Accessibility Buttons available) |
- XMLFull Document: Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug) [1 KB] |
- PDFFull Document: Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug) [62 KB]
Regulations are current to 2024-11-26 and last amended on 2021-12-22. Previous Versions
Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug)
SOR/2020-213
[Repealed, SOR/2021-274, s. 1] - 2021-12-22
Registration 2020-09-28
Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug)
- Date modified: